Current State of Radiolabeled Heterobivalent Peptidic Ligands in Tumor Imaging and Therapy

Over the past few years, an approach emerged that combines different receptor-specific peptide radioligands able to bind different target structures on tumor cells concomitantly or separately. The reason for the growing interest in this special field of radiopharmaceutical development is rooted in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Judmann, Benedikt, Braun, Diana, Wängler, Björn, Schirrmacher, Ralf, Fricker, Gert, Wängler, Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465997/
https://www.ncbi.nlm.nih.gov/pubmed/32751666
http://dx.doi.org/10.3390/ph13080173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465997/
https://www.ncbi.nlm.nih.gov/pubmed/32751666
http://dx.doi.org/10.3390/ph13080173

Ejemplares similares